Literature DB >> 10700391

The existence of a lysosomal redox chain and the role of ubiquinone.

L Gille1, H Nohl.   

Abstract

Several studies concerning the distribution of ubiquinone (UQ) in the cell report a preferential accumulation of this biogenic quinone in mitochondria, plasma membranes, Golgi vesicles, and lysosomes. Except for mitochondria, no recent comprehensive experimental evidence exists on the particular function of UQ in these subcellular organelles. The aim of a recent study was to elucidate whether UQ is an active part of an electron-transfer system in lysosomes. In the present work, a lysosomal fraction was prepared from a light mitochondrial fraction of rat liver by isopycnic centrifugation. The purity of our preparation was verified by estimation of the respective marker enzymes. Analysis of lysosomes for putative redox carriers and redox processes in lysosomes was carried out by optical spectroscopy, HPLC, oxymetry, and ESR techniques. UQ was detected in an amount of 2.2 nmol/mg of protein in lysosomes. Furthermore, a b-type cytochrome and a flavin-adenine dinucleotide (FAD) were identified as other potential electron carriers. Since NADH was reported to serve as a substrate of UQ redox chains in plasma membranes, we also tested this reductant in lysosomes. Our experiments demonstrate a NADH-dependent reduction of UQ by two subsequent one-electron-transfer steps giving rise to the presence of ubisemiquinone and an increase of the ubiquinol pool in lysosomes. Lysosomal NADH oxidation was accompanied by an approximately equimolar oxygen consumption, suggesting that O(2) acts as a terminal acceptor of this redox chain. DMPO/(*)OH spin adducts were detected by ESR in NADH-supplemented lysosomes, suggesting a univalent reduction of oxygen. The kinetic analysis of redox changes in lysosomes revealed that electron carriers operate in the sequence NADH > FAD > cytochrome b > ubiquinone > oxygen. By using the basic spin label TEMPAMINE, we showed that the NADH-related redox chain in lysosomes supports proton accumulation in lysosomes. In contrast to the hypothesis that UQ in lysosomes is simply a waste product of autophagy in the cell, we demonstrated that this lipophilic electron carrier is a native constituent of a lysosomal electron transport chain, which promotes proton translocation across the lysosomal membrane. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10700391     DOI: 10.1006/abbi.1999.1649

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

1.  Phenotypic and suppressor analysis of defecation in clk-1 mutants reveals that reaction to changes in temperature is an active process in Caenorhabditis elegans.

Authors:  R Branicky; Y Shibata; J Feng; S Hekimi
Journal:  Genetics       Date:  2001-11       Impact factor: 4.562

Review 2.  Endolysosomal proteolysis and its regulation.

Authors:  Ché S Pillay; Edith Elliott; Clive Dennison
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Ubiquinone synthesis in mitochondrial and microsomal subcellular fractions of Pneumocystis spp.: differential sensitivities to atovaquone.

Authors:  Mireille Basselin; Shannon M Hunt; Hiam Abdala-Valencia; Edna S Kaneshiro
Journal:  Eukaryot Cell       Date:  2005-08

Review 4.  Role of ROS and RNS Sources in Physiological and Pathological Conditions.

Authors:  Sergio Di Meo; Tanea T Reed; Paola Venditti; Victor Manuel Victor
Journal:  Oxid Med Cell Longev       Date:  2016-07-12       Impact factor: 6.543

5.  Discovery of plastoquinones: a personal perspective.

Authors:  Frederick L Crane
Journal:  Photosynth Res       Date:  2010-03-09       Impact factor: 3.573

Review 6.  Coenzyme Q and mitochondrial disease.

Authors:  Catarina M Quinzii; Michio Hirano
Journal:  Dev Disabil Res Rev       Date:  2010

7.  The existence and significance of redox-cycling ubiquinone in lysosomes.

Authors:  H Nohl; L Gille
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

8.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

9.  Cytosolic activation of cathepsins mediates parvovirus H-1-induced killing of cisplatin and TRAIL-resistant glioma cells.

Authors:  Matteo Di Piazza; Carmen Mader; Karsten Geletneky; Marta Herrero Y Calle; Ekkehard Weber; Jörg Schlehofer; Laurent Deleu; Jean Rommelaere
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 10.  Oxygen free radicals and redox biology of organelles.

Authors:  Leni Moldovan; Nicanor I Moldovan
Journal:  Histochem Cell Biol       Date:  2004-09-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.